Skip to content
Dose Brief
Menu
No. 8 on the board · Grade B

MadeMed review

Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.

Visit MadeMed Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$239/mo injectable · $219/mo sublingual (quarterly)
Tirzepatide
$399/mo injectable · $299/mo sublingual (quarterly)
Coverage
40 states
Brand-name
Compounded only
On the trackerStableprice stablePublishes one price per route that holds at every dose — the cleanest dose-to-price mapping we track.

The scorecard

MadeMed scored on our six Brief Score factors. See the methodology.

Price Stability92/100
Supply Reliability84/100
Transparency94/100
Access Breadth76/100
Clinical Oversight84/100
Track Record82/100

What we like

  • One published price per route that does not change as the dose climbs, so a titration schedule can be costed exactly
  • Sublingual tablets for BOTH molecules alongside the injections — a needle-free route at a lower price than the injection
  • Six-month plans drop the monthly rate below the quarterly headline
  • LegitScript-verified with board-certified physician review

The caveats

  • Flat-at-every-dose pricing means a reader holding a low dose pays the full-dose rate
  • Billed quarterly rather than monthly, so the real commitment is three months of cost up front
  • Available in 40 states rather than nationwide
  • Compounded only — no brand-name pathway

The brief

Best for: Readers who want to know the exact cost of a titrated dose before starting, and who intend to climb to a full dose. Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.

Ranked #8 of 39 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest MadeMed — the realistic shortlist if you're weighing it.

Every other provider we track (32)

Pricing, states and verification reflect MadeMed's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on MadeMed's site. Not medical advice; see our disclosure.

← Back to all rankings